Boston Children's Hospital Case Study
Researchers at Boston Children’s Hospital successfully leveraged electronic genome mapping (EGM) to verify a complex structural variant (SV) in the PHEX gene. Led by Dr. Catherine Brownstein, the team utilized the OhmX Analyzer to confirm a 60,150 bp tandem duplication in a case of X-linked hypophosphatemia. EGM’s precise detection, enabled by ultra-high molecular weight DNA tagging and resistance-based electronic sensing, overcame the limitations of traditional sequencing and optical genome mapping.
This study underscores the transformative potential of EGM in rare disease research. Its ability to detect challenging SVs with accuracy and efficiency bridges the gap between short-read sequencing and traditional cytogenetic techniques. By combining SV Discovery and Variant Verification pipelines, EGM paves the way for more comprehensive genomic insights, advancing the understanding of structural variations and their implications for rare genetic conditions. Learn more at nabsys.com/learn/electronic-genome-mapping.